Market News Video
MNV MNV 10 Stocks Crossing Above Their 200 Day Moving Average
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

First Week of February 2021 Options Trading For Atara Biotherapeutics
Monday, December 21, 10:55 AM ET, by Market News Video Staff

Investors in Atara Biotherapeutics Inc (ATRA) saw new options become available this week, for the ...

Atara Biotherapeutics Breaks Below 200-Day Moving Average - Notable for ATRA
Wednesday, March 3, 6:20 PM ET, by Market News Video Staff

In trading on Wednesday, shares of Atara Biotherapeutics Inc (ATRA) crossed below their 200 day ...

Atara BiotherapeuticsBecomes Oversold (ATRA)
Friday, March 26, 11:55 AM ET, by Market News Video Staff

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...

VBK's Holdings Imply 13% Gain Potential
Monday, March 29, 8:38 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

Top Buys by Top Brass: Chief Commercial Officer Yarema's $500.4K Bet on ATRA
Wednesday, June 16, 10:27 AM ET, by Market News Video Staff

A company's own top management tend to have the best inside view into the business, ...

Atara BiotherapeuticsBecomes Oversold (ATRA)

By Market News Video Staff, Friday, March 26, 11:55 AM ET
Play Video: Learn About The RSI

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Email EnvelopeFree Email Alerts By Stock:
Get Dividend Alerts
Get SEC Filing Alerts

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Friday, shares of Atara Biotherapeutics Inc (NASDAQ:ATRA) entered into oversold territory, hitting an RSI reading of 28.3, after changing hands as low as $14.17 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 52.3. A bullish investor could look at ATRA's 28.3 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of ATRA shares:

Atara Biotherapeutics Inc 1 Year Performance Chart

Looking at the chart above, ATRA's low point in its 52 week range is $7.14 per share, with $28.20 as the 52 week high point — that compares with a last trade of $14.32. Find out what 9 other oversold stocks you need to know about »

Can your brain be trained to become a chart-predicting wizard? Click here to find out

This Article's Word Cloud:   ATRA   About   Atara   Biotherapeutics   Buffett   Click   Find   Friday   Index   Know   Legendary   Looking   Oversold   Relative   Should   Start   Stocks   Strength   Warren   about   above   advises   after   analysis   become   begin   below   brain   bullish   called   changing   chart   compares   comparison   fearful   greedy   investor   look   others   oversold   point   raquo   reading   share   shares   stock   that   week   when   with
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy
Home  |  Analyst News  Dividend Report  ETFs  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV MNV Chart Zero Stock Market Game Stock Market Definitions

Atara BiotherapeuticsBecomes Oversold (ATRA) | Market News Video | Copyright © 2008 - 2021, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.